Virtual Reality Exposure for Public Speaking Anxiety

NCT ID: NCT06214039

Last Updated: 2024-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-14

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-week online transition intervention. Previous studies have demonstrated that one-session therapy (OST) is comparable to prolonged exposure-based therapies in terms of effectively reducing public speaking anxiety. Moreover, VR offers many benefits compared to in-person exposure, namely the ability to produce anxiety-evoking stimuli without having to leave the therapist's room. However, OST VR exposure has not been directly compared to prolonged VR exposure and not for public speaking anxiety.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Public Speaking Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

One session therapy

One session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand

Group Type ACTIVE_COMPARATOR

Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety

Intervention Type BEHAVIORAL

A 3-hour one session exposure therapy for public speaking anxiety

One session therapy - divided into 3

Three session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand

Group Type EXPERIMENTAL

Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety

Intervention Type BEHAVIORAL

A 3-hour one session exposure therapy for public speaking anxiety

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety

A 3-hour one session exposure therapy for public speaking anxiety

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 18-30 and studying in higher education;
* experiencing a significant level of public speaking anxiety (60+ on PSAS);
* able to use a computer and have access to the internet for the duration of the study;
* able to understand, write and speak in Lithuanian;
* available to participate in one or three in-person intervention sessions and can devote the time to participate in a 4-week online program following the intervention sessions.

Exclusion Criteria

* a history of seizures or a history of epilepsy;
* other significant medical conditions that would prevent them from participating in the program;
* high levels of depression (Patient Health Questionnaire-9 rating of 15 and above and mentions of suicidal ideation) or other significant psychiatric conditions that would interfere with participation in the program;
* a tendency to have extreme seasickness reactions or a history of adverse physical reactions to virtual reality experiences or difficulty with or lack of stereoscopic vision;
* current involvement in other psychological interventions such as psychological counseling or psychotherapy;
* use of psychoactive drugs, unless stable for three months;
* current participation in other programs aimed at reducing public speaking anxiety.
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Linkoeping University

OTHER_GOV

Sponsor Role collaborator

Stockholm University

OTHER

Sponsor Role collaborator

Thomas More University of Applied Sciences

OTHER

Sponsor Role collaborator

Vilnius University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonas Eimontas, PhD

Role: STUDY_CHAIR

Vilnius University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vilnius University

Vilnius, , Lithuania

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Lithuania

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jonas Eimontas, PhD

Role: CONTACT

+37052667615

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jonas Eimontas, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VRanx_001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Virtual Reality for Youth Phobias
NCT05839431 COMPLETED NA